For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230517:nRSQ6417Za&default-theme=true
RNS Number : 6417Z Cellular Goods PLC 17 May 2023
Press release
17 May 2023
Cellular Goods PLC
("Cellular Goods" or "the Company")
Products live on Sephora
Further to the announcement of 10 May 2023, Cellular Goods is pleased to
announce that it has commenced selling its 'Look Better' (skincare) range and
selected products from its 'Gift Better' (gifting) line on Sephora.co.uk. Ten
products in total are available, ranging in price from £32 to £99 each.
The launch is part of the Company's strategy to drive revenues by expanding
its online sales channel with major retail brands.
Darcy Taylor, chairman and interim CEO, commented: "We're thrilled that our
Look Better and Gift Better ranges are on sale at Sephora, and are excited to
be working alongside them to bring our next-generation skincare products to a
wider audience."
For further information please contact:
Cellular Goods
Darcy Taylor via Tancredi +44 207 887 7633
Chairman and interim CEO
Neil Thapar +44 787 645 5323
Investor Relations
First Sentinel Corporate Finance
Corporate Broker & Advisor
Brian Stockbridge +44 7876 888 011
Novum Securities
Corporate Broker
Colin Rowbury
Jon Belliss +44 207 399 9427
Tancredi Intelligent Communication
Media Relations
Helen Humphrey +44 744 922 6720
Charlie Hobbs +44 789 755 7112
cellulargoods@tancredigroup.com (mailto:cellulargoods@tancredigroup.com)
About Cellular Goods PLC:
Cellular Goods develops and markets premium quality skincare and wellness
products based on proprietary formulations incorporating biosynthetic lab-made
cannabinoids. Our branded products are efficacy-led and research-backed and
available online in the UK and US. The Company is incorporated in the UK and
listed on the Main Market of the London Stock Exchange. For more information,
visit www.cellular-goods.com (http://www.cellular-goods.com) .
This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END NRANKABKFBKDAPD